- recruitingTherapeutic confirmatory (Phase III)
A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of dupilumab for the treatment of pruritus of Lichen Simplex Chronicus (LSC) in adults
This study tests whether a medicine called dupilumab can help adults with lichen simplex chronicus, also known as neurodermatitis. Researchers want to see if the treatment relieves severe itching, improves sleep, and clears thickened patches of skin compared to a dummy injection (placebo) over 24 weeks.
Hungary · Italy · Germany - recruitingTherapeutic confirmatory (Phase III)
A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of dupilumab for the treatment of pruritus of Lichen Simplex Chronicus (LSC) in adults
This clinical trial is testing a medicine called dupilumab for adults with lichen simplex chronicus, also known as neurodermatitis. This condition causes thick, intensely itchy patches of skin. Researchers want to see if regular dupilumab injections can safely reduce itching, improve sleep, and help clear the skin compared to a dummy drug.
Greece · Germany · Spain